UniQure Screens HD Patients for Gene Therapy Trial

UniQure, a Netherlands-based company, has started to screen Huntington's disease patients for its gene therapy trial, set to begin in late 2019 or early 2020. Twenty-six patients will be treated with either a single dose of gene therapy directly into the striatum or an imitation procedure with no drug. Read more here: https://pharmaphorum.com/news/uniqure-presses-go-on-huntingtons-gene-therapy-trial/?fbclid=IwAR1u8WtIxQm7xBnA6wRKTgOLmUv_LcWOo_1xbGvONjitl1ZHkShHBitcC9E

View All Posts